• WindMIL Therapeutics and Cognate BioServices Enter Agreement contractpharma
    March 11, 2020
    WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs) for cancer immunotherapy, and Cognate BioServices, a contract development and manufacturing organization (CDMO) ...
PharmaSources Customer Service